Who Helped Pave the Way for Remdesivir? An Explosive Conversation

The Plandemonium, Part 13

For more articles on the Plandemonium, click here.

Remdesivir is a drug with a strange history, and that became oddly inserted into the Plandemonium despite no history of success as a practical antiviral. The expensive drug became the standard of care in many hospitals, despite the fact that antivirals are not expected to be particularly effective more than about five days after symptomatic infection. Many people believe the drug to be a killer.

So, just how did remdesivir pass through the sieve of medical testing to emerge as a late stage COVID-19 treatment?

Tomorrow at 1 PM Eastern, five researchers who have collectively spent thousands of hours gathering information about the emergence of remdesivir as an accepted treatment for COVID-19 gather for a comprehensive discussion that includes roles played along the way by Dr. Robert Malone and COVID Early Treatment Foundation manager Steve Kirsch, among many others. If you care about this topic, you should join us live, or watch the recording.

https://rumble.com/v2o0mpk-remdesivir-plandemonium-round-table-w-jonathan-couey-mark-kulacz-and-george.html